Award
NIH Reporter #5R01CA257251-05
Targeting CDK6 expression/activity in Ph+ and Ph1-like acute lymphoblastic leukemia (ALL)
Recipient
Thomas Jefferson University, Philadelphia, PA, United States
Award Amount
$631,337.00
Ceiling
$631,337.00
Awarded
June 17, 2025
Identifier
5R01CA257251-05
NIH research grant awarded to Thomas Jefferson University for targeting CDK6 in acute lymphoblastic leukemia with a total award amount of $631,337.
Description
Research grant opportunity from the NIH for projects related to leukemia and cancer therapeutics focusing on targeting CDK6 in leukemia cells using PROTACs.